Clinical Trials
3 trialsNCT02327169 2020-02-25
A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic Malignancies
Takeda
Phase 1 Completed
NCT01899053 2019-10-30
A Safety and Pharmacokinetic Study of TAK-228 in Combination With TAK-117 in Adult Participants With Advanced Nonhematologic Malignancies
Takeda
Phase 1 Completed
NCT00677170 2013-07-16
Study of MLN4924 in Adult Patients With Nonhematologic Malignancies
Millennium Pharmaceuticals, Inc.
Phase 1 Completed